Selected research
Industry Research
Radix Isatidis Industry Research Report 2026
Market perspective
The global Radix Isatidis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Radix Isatidis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Radix Isatidis is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Radix Isatidis is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Radix Isatidis include Revised Pharmaceutical Group Limited by Share Ltd, Guangzhou Baiyun Mountain Pharmaceutical Group, Guangzhou Xiangxue pharmaceutical Limited by Share Ltd, Huarun 39 pharmaceuticals Limited by Share Ltd, Anhui Hua Tuo national drug Limited by Share Ltd, Jilin Aodong Pharmaceutical Group Corporation, Li Shizhen Medical Group Ltd, Taiji Group Ltd and Yunnan Baiyao Group Limited by Share Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Radix Isatidis market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Radix Isatidis Market by Company
Revised Pharmaceutical Group Limited by Share Ltd
Guangzhou Baiyun Mountain Pharmaceutical Group
Guangzhou Xiangxue pharmaceutical Limited by Share Ltd
Huarun 39 pharmaceuticals Limited by Share Ltd
Anhui Hua Tuo national drug Limited by Share Ltd
Jilin Aodong Pharmaceutical Group Corporation
Li Shizhen Medical Group Ltd
Taiji Group Ltd
Yunnan Baiyao Group Limited by Share Ltd
China Beijing Tongrentang (Group) Co., Ltd.
Radix Isatidis Segment by Type
Grain
Capsule
Other
Radix Isatidis Segment by Application
Pharmacy
Hospital
Other
Radix Isatidis Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radix Isatidis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radix Isatidis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radix Isatidis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Radix Isatidis manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Radix Isatidis by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Radix Isatidis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Grain
- Capsule
- Other
Applications
- Pharmacy
- Hospital
- Other
Companies covered
- Revised Pharmaceutical Group Limited by Share Ltd
- Guangzhou Baiyun Mountain Pharmaceutical Group
- Guangzhou Xiangxue pharmaceutical Limited by Share Ltd
- Huarun 39 pharmaceuticals Limited by Share Ltd
- Anhui Hua Tuo national drug Limited by Share Ltd
- Jilin Aodong Pharmaceutical Group Corporation
- Li Shizhen Medical Group Ltd
- Taiji Group Ltd
- Yunnan Baiyao Group Limited by Share Ltd
- China Beijing Tongrentang (Group) Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Radix Isatidis Market Size (2021-2032)
- 2.2.2 Global Radix Isatidis Sales (2021-2032)
- 2.2.3 Global Radix Isatidis Market Average Price (2021-2032)
- 2.3 Radix Isatidis by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Grain
- 2.3.3 Capsule
- 2.3.4 Other
- 2.4 Radix Isatidis by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmacy
- 2.4.3 Hospital
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Radix Isatidis Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Radix Isatidis Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Radix Isatidis Revenue of Manufacturers (2021-2026)
- 3.4 Global Radix Isatidis Average Price by Manufacturers (2021-2026)
- 3.5 Global Radix Isatidis Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Radix Isatidis, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Radix Isatidis, Product Type & Application
- 3.8 Global Manufacturers of Radix Isatidis, Established Date
- 3.9 Global Radix Isatidis Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Revised Pharmaceutical Group Limited by Share Ltd
- 4.1.1 Revised Pharmaceutical Group Limited by Share Ltd Company Information
- 4.1.2 Revised Pharmaceutical Group Limited by Share Ltd Business Overview
- 4.1.3 Revised Pharmaceutical Group Limited by Share Ltd Radix Isatidis Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Revised Pharmaceutical Group Limited by Share Ltd Radix Isatidis Product Portfolio
- 4.1.5 Revised Pharmaceutical Group Limited by Share Ltd Recent Developments
- 4.2 Guangzhou Baiyun Mountain Pharmaceutical Group
- 4.2.1 Guangzhou Baiyun Mountain Pharmaceutical Group Company Information
- 4.2.2 Guangzhou Baiyun Mountain Pharmaceutical Group Business Overview
- 4.2.3 Guangzhou Baiyun Mountain Pharmaceutical Group Radix Isatidis Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Guangzhou Baiyun Mountain Pharmaceutical Group Radix Isatidis Product Portfolio
- 4.2.5 Guangzhou Baiyun Mountain Pharmaceutical Group Recent Developments
- 4.3 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd
- 4.3.1 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd Company Information
- 4.3.2 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd Business Overview
- 4.3.3 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd Radix Isatidis Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd Radix Isatidis Product Portfolio
- 4.3.5 Guangzhou Xiangxue pharmaceutical Limited by Share Ltd Recent Developments
- 4.4 Huarun 39 pharmaceuticals Limited by Share Ltd
- 4.4.1 Huarun 39 pharmaceuticals Limited by Share Ltd Company Information
- 4.4.2 Huarun 39 pharmaceuticals Limited by Share Ltd Business Overview
- 4.4.3 Huarun 39 pharmaceuticals Limited by Share Ltd Radix Isatidis Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Huarun 39 pharmaceuticals Limited by Share Ltd Radix Isatidis Product Portfolio
- 4.4.5 Huarun 39 pharmaceuticals Limited by Share Ltd Recent Developments
- 4.5 Anhui Hua Tuo national drug Limited by Share Ltd
- 4.5.1 Anhui Hua Tuo national drug Limited by Share Ltd Company Information
- 4.5.2 Anhui Hua Tuo national drug Limited by Share Ltd Business Overview
- 4.5.3 Anhui Hua Tuo national drug Limited by Share Ltd Radix Isatidis Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Anhui Hua Tuo national drug Limited by Share Ltd Radix Isatidis Product Portfolio
- 4.5.5 Anhui Hua Tuo national drug Limited by Share Ltd Recent Developments
- 4.6 Jilin Aodong Pharmaceutical Group Corporation
- 4.6.1 Jilin Aodong Pharmaceutical Group Corporation Company Information
- 4.6.2 Jilin Aodong Pharmaceutical Group Corporation Business Overview
- 4.6.3 Jilin Aodong Pharmaceutical Group Corporation Radix Isatidis Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jilin Aodong Pharmaceutical Group Corporation Radix Isatidis Product Portfolio
- 4.6.5 Jilin Aodong Pharmaceutical Group Corporation Recent Developments
- 4.7 Li Shizhen Medical Group Ltd
- 4.7.1 Li Shizhen Medical Group Ltd Company Information
- 4.7.2 Li Shizhen Medical Group Ltd Business Overview
- 4.7.3 Li Shizhen Medical Group Ltd Radix Isatidis Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Li Shizhen Medical Group Ltd Radix Isatidis Product Portfolio
- 4.7.5 Li Shizhen Medical Group Ltd Recent Developments
- 4.8 Taiji Group Ltd
- 4.8.1 Taiji Group Ltd Company Information
- 4.8.2 Taiji Group Ltd Business Overview
- 4.8.3 Taiji Group Ltd Radix Isatidis Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Taiji Group Ltd Radix Isatidis Product Portfolio
- 4.8.5 Taiji Group Ltd Recent Developments
- 4.9 Yunnan Baiyao Group Limited by Share Ltd
- 4.9.1 Yunnan Baiyao Group Limited by Share Ltd Company Information
- 4.9.2 Yunnan Baiyao Group Limited by Share Ltd Business Overview
- 4.9.3 Yunnan Baiyao Group Limited by Share Ltd Radix Isatidis Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Yunnan Baiyao Group Limited by Share Ltd Radix Isatidis Product Portfolio
- 4.9.5 Yunnan Baiyao Group Limited by Share Ltd Recent Developments
- 4.10 China Beijing Tongrentang (Group) Co., Ltd.
- 4.10.1 China Beijing Tongrentang (Group) Co., Ltd. Company Information
- 4.10.2 China Beijing Tongrentang (Group) Co., Ltd. Business Overview
- 4.10.3 China Beijing Tongrentang (Group) Co., Ltd. Radix Isatidis Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 China Beijing Tongrentang (Group) Co., Ltd. Radix Isatidis Product Portfolio
- 4.10.5 China Beijing Tongrentang (Group) Co., Ltd. Recent Developments
5 Global Radix Isatidis Market Scenario by Region
- 5.1 Global Radix Isatidis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Radix Isatidis Sales by Region: 2021-2032
- 5.2.1 Global Radix Isatidis Sales by Region: 2021-2026
- 5.2.2 Global Radix Isatidis Sales by Region: 2027-2032
- 5.3 Global Radix Isatidis Revenue by Region: 2021-2032
- 5.3.1 Global Radix Isatidis Revenue by Region: 2021-2026
- 5.3.2 Global Radix Isatidis Revenue by Region: 2027-2032
- 5.4 North America Radix Isatidis Market Facts & Figures by Country
- 5.4.1 North America Radix Isatidis Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Radix Isatidis Sales by Country (2021-2032)
- 5.4.3 North America Radix Isatidis Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Radix Isatidis Market Facts & Figures by Country
- 5.5.1 Europe Radix Isatidis Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Radix Isatidis Sales by Country (2021-2032)
- 5.5.3 Europe Radix Isatidis Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Radix Isatidis Market Facts & Figures by Country
- 5.6.1 Asia Pacific Radix Isatidis Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Radix Isatidis Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Radix Isatidis Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Radix Isatidis Market Facts & Figures by Country
- 5.7.1 South America Radix Isatidis Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Radix Isatidis Sales by Country (2021-2032)
- 5.7.3 South America Radix Isatidis Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Radix Isatidis Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Radix Isatidis Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Radix Isatidis Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Radix Isatidis Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Radix Isatidis Sales by Type (2021-2032)
- 6.1.1 Global Radix Isatidis Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Radix Isatidis Sales Market Share by Type (2021-2032)
- 6.2 Global Radix Isatidis Revenue by Type (2021-2032)
- 6.2.1 Global Radix Isatidis Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Radix Isatidis Revenue Market Share by Type (2021-2032)
- 6.3 Global Radix Isatidis Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Radix Isatidis Sales by Application (2021-2032)
- 7.1.1 Global Radix Isatidis Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Radix Isatidis Sales Market Share by Application (2021-2032)
- 7.2 Global Radix Isatidis Revenue by Application (2021-2032)
- 7.2.1 Global Radix Isatidis Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Radix Isatidis Revenue Market Share by Application (2021-2032)
- 7.3 Global Radix Isatidis Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Radix Isatidis Value Chain Analysis
- 8.1.1 Radix Isatidis Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Radix Isatidis Production Mode & Process
- 8.2 Radix Isatidis Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Radix Isatidis Distributors
- 8.2.3 Radix Isatidis Customers
9 Global Radix Isatidis Analyzing Market Dynamics
- 9.1 Radix Isatidis Industry Trends
- 9.2 Radix Isatidis Industry Drivers
- 9.3 Radix Isatidis Industry Opportunities and Challenges
- 9.4 Radix Isatidis Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst